NASDAQ · QTI
QT Imaging Holdings, Inc.
$2.21-$0.07 (-3.07%)
QT Imaging Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.92% below the high.
Loading market information…
NASDAQ · NURO · USD
Stock price, dividends, earnings
Quote as of May 1, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
NeuroMetrix, Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.17% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow NeuroMetrix, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:26 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
THE ANALYST VIEW
2 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$2.21-$0.07 (-3.07%)
QT Imaging Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.92% below the high.
$1.75-$0.46 (-20.81%)
CervoMed Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.5% below the high.
$1.52-$0.09 (-5.59%)
China Jo-Jo Drugstores, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.22% below the high.
$0.84+$0.01 (+1.07%)
Field Trip Health Ltd.: Healthcare · Medical - Care Facilities.
$0.39+$0.03 (+8.48%)
Apexigen, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.35% below the high.
$0.33+$0.33 (+100.0%)
Centogene N.V.’s quoted price sits in the lower half of its reported 52-week range, 24.24% below the high.
$5.20+$1.69 (+48.15%)
TNF Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.33% below the high.
$0.47$0.00 (0.0%)
ProSomnus, Inc.’s quoted price sits in the lower half of its reported 52-week range, 6.0% below the high.
